期刊文献+

基于羟基磷灰石的丹酚酸组分磷脂复合物共沉淀物的制备研究 被引量:2

Studies on hydroxyapatite applicatied in coprecipitate of total salvianolic acids phospholipid complex
原文传递
导出
摘要 该实验旨在制备丹酚酸组分磷脂复合物的羟基磷灰石(HA)共沉淀物,以提高药物的体外溶出,同时改善丹酚酸组分磷脂复合物的粉体学性质。首先采用溶剂法制备共沉淀物,以丹酚酸组分中的丹酚酸B和丹参素为指标成分考察其体外溶出,同时对其进行粉体学性质的考察,并利用DSC,XRD,FTIR等表征手段对其结构特征进行分析研究。结果可得丹酚酸组分磷脂复合物与羟基磷灰石按1∶2制备的共沉淀物的体外溶出效果较好,60 min时药物的体外累积溶出率达到90%以上;粉体学性质考察结果表明该共沉淀物流动性良好,吸湿性低,粉体学性质得到了较大的改善,微观结构的表征分析表明药物仍旧以非晶形式存在。该实验的制备工艺简单可行,具有实际应用价值。 The purpose of this research was to prepare total salvianolic acids-phytosome-HA coprecipitate to improve drug dissolution and its micromeritic properties. Firstly, the coprecipitate was prepared by solvent method and in vitro dissolution of tripterine was performed with the salvianolic acid B and danshensu as criteria.At the same time, the micromeritic properties was characterizated, the structure of samples was characterized by TEM,DSC,XRD and FTIR.Results showed that when the ratio of drug to HA was 1:2, it had a better dissolution, the accumulative drug-release percent in vitro at 60 min was over 90%. At the same time, it has good liquidityand low moisture absorption.Its micromeritic properties have improved. It is proved that the drug still existed amorphously by microstructure analysis. The preparation process is simple and feasible,it has practical value.
出处 《中国中药杂志》 CAS CSCD 北大核心 2014年第6期992-996,共5页 China Journal of Chinese Materia Medica
基金 国家"十一五"科技支撑计划项目(2008BAI51B03) 江苏省中医药领军人才专项(2006)
关键词 丹酚酸组分磷脂复合物 羟基磷灰石 共沉淀物 粉体学性质 total salvianolic acids phospholipid complex hydroxyapatite coprecipitate micromeritic properties
  • 相关文献

参考文献10

  • 1刘丹,郁丹红,孙娥,贾晓斌.中药组分与组分生物药剂学分类系统构建[J].中国中药杂志,2012,37(19):2997-3000. 被引量:27
  • 2陈小云,张振海,刘丹,郁丹红,孙娥,贾晓斌.丹酚酸组分磷脂复合物制备研究[J].中国中药杂志,2014,39(2):216-221. 被引量:9
  • 3Rao S, Nagabhushanam M V, Chowdary K P R. In vitro dissolu- tion studies on solid dispersions of mefenamic acid [ J ]. Indian J Pharm Sci,2011,73(2) :243.
  • 4Ha J M, Kang S Y, Park C W,et al. Effect of poloxamer on physicochemical properties of tacrolimus solid dispersion impro- ving water solubility and dissolution rate [ J ]. J Pharol Invest, 2012,42(4) : 171.
  • 5杜焰,赵立杰,熊耀坤,李晓海,王松涛,冯怡,徐德生.药用粉体流动性的多元分析方法表征[J].药学学报,2012,47(9):1231-1236. 被引量:14
  • 6Zhou Q T, Armstrong B,Larson I,et al. Understanding the influ- ence of powder flowability, fluidization and de-agglomerationcharacteristics on the aerosolization of pharmaceutical model pow- ders[J]. Eur J Pharm Sci,2010,40(5) :412.
  • 7郁丹红,刘丹,贾晓斌,等.基于生物药剂学忡质的中药组分剂型的设计技术[J].中国实验方剂学杂志,2012,37(19):2993.
  • 8李小妹,康志英,梁咏,麻印莲,于定荣.HPLC测定中风回春胶囊中丹酚酸B的含量[J].中国实验方剂学杂志,2013,19(13):122-124. 被引量:5
  • 9Sun S P, Wei M, Olson J R, et al. Shaw biodegradable composites with aligned hydroxyapatite nanoneedles[ J]. J Biomed Mater Res B,2012,100B(7) :1817.
  • 10Pang X F, Zhou H W, Liu J L, et al. Investigation of biological property of nanohydroxyapatite materials [ J]. J Nanosci Nano- technol, 2012, 12(2) :894.

二级参考文献62

共引文献51

同被引文献26

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部